mitoxantrone has been researched along with estrone in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (53.33) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Imai, Y; Sugimoto, Y; Tsukahara, S; Tsuruo, T; Ueda, K | 1 |
| Asada, S; Imai, Y; Ishikawa, E; Sugimoto, Y; Tsukahara, S; Tsuruo, T | 1 |
| Asada, S; Imai, Y; Ishikawa, E; Miwa, M; Sugimoto, Y; Tsukahara, S | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Imai, Y; Ishikawa, E; Sugimoto, Y; Tsukahara, S; Tsuruo, T | 1 |
| Devane, CL; Donovan, JL; Markowitz, JS; Wang, JS; Yuan, HJ; Zhu, HJ | 1 |
| Gao, P; Gao, Y; Li, G; Wang, H; Wei, F; Wei, L; Yin, D; Yu, J; Zhang, X; Zhang, Y; Zhou, G | 1 |
| Anzai, N; Ikebuchi, Y; Ito, K; Kanai, Y; Suzuki, H; Takada, T | 1 |
| Chen, J; Cong, D; Hao, Q; Jiao, Q; Li, H; Li, Y; Liu, K; Liu, X; Luan, X; Pei, J; Sun, Y; Tian, L; Wang, L; Wang, Z; Xu, G; Yang, Y; Zhang, Z | 1 |
| Bao, H; Chen, J; Cong, D; Hao, Q; Li, Q; Li, Y; Lv, Z; Meng, Q; Pei, J; Ren, Z; Sun, Y; Tang, H; Xie, Y; Xu, G; Zhu, M | 1 |
3 review(s) available for mitoxantrone and estrone
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
Membrane transporters in drug development.
Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs | 2010 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
12 other study(ies) available for mitoxantrone and estrone
| Article | Year |
|---|---|
Reversal of breast cancer resistance protein-mediated drug resistance by estrogen antagonists and agonists.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Breast Neoplasms; Cell Survival; Diethylstilbestrol; Drug Resistance, Neoplasm; Estrogen Antagonists; Estrogens; Estrone; Female; Humans; K562 Cells; Kinetics; Mitoxantrone; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Tamoxifen; Topotecan; Tumor Cells, Cultured | 2003 |
Breast cancer resistance protein exports sulfated estrogens but not free estrogens.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Breast Neoplasms; Cell Line; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Estrogens; Estrogens, Conjugated (USP); Estrone; LLC-PK1 Cells; Models, Molecular; Neoplasm Proteins; Sulfates; Swine | 2003 |
Single amino acid substitutions in the transmembrane domains of breast cancer resistance protein (BCRP) alter cross resistance patterns in transfectants.
Topics: Amino Acid Substitution; Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Camptothecin; Cell Line; Cell Membrane; DNA, Complementary; Drug Resistance, Multiple; Fibroblasts; Humans; Irinotecan; Kinetics; Mice; Mitoxantrone; Neoplasm Proteins; Recombinant Proteins; Transfection | 2003 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Estrone and 17beta-estradiol reverse breast cancer resistance protein-mediated multidrug resistance.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Camptothecin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Estradiol; Estrone; Female; Flow Cytometry; Humans; Irinotecan; K562 Cells; Mitoxantrone; Neoplasm Proteins; Topoisomerase I Inhibitors; Topotecan; Transfection | 2002 |
Antipsychotic drugs inhibit the function of breast cancer resistance protein.
Topics: Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Caco-2 Cells; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Interactions; Estrone; Flow Cytometry; Humans; Inactivation, Metabolic; Mitoxantrone; Neoplasm Proteins; Substrate Specificity | 2008 |
Transcriptional modulation of BCRP gene to reverse multidrug resistance by toremifene in breast adenocarcinoma cells.
Topics: Adenocarcinoma; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Binding Sites; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Electrophoretic Mobility Shift Assay; Estrogen Receptor alpha; Estrone; Female; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Mitoxantrone; Neoplasm Proteins; Promoter Regions, Genetic; RNA, Messenger; Selective Estrogen Receptor Modulators; Toremifene; Transcription, Genetic; Transfection | 2010 |
Receptor for activated C-kinase 1 regulates the cell surface expression and function of ATP binding cassette G2.
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Drug Resistance; Estrone; GTP-Binding Proteins; HeLa Cells; Humans; Mitoxantrone; Neoplasm Proteins; Receptors for Activated C Kinase; Receptors, Cell Surface; RNA, Small Interfering | 2010 |
Oestrone-targeted liposomes for mitoxantrone delivery via oestrogen receptor - synthesis, physicochemical characterization and in-vitro evaluation.
Topics: Cell Proliferation; Chemical Phenomena; Drug Delivery Systems; Drug Evaluation, Preclinical; Estrone; HL-60 Cells; Humans; Liposomes; Mitoxantrone; Receptors, Estrogen | 2017 |
Estrone-targeted liposomes for mitoxantrone delivery via estrogen receptor: In vivo targeting efficacy, antitumor activity, acute toxicity and pharmacokinetics.
Topics: Antineoplastic Agents; Cell Line, Tumor; Estrone; Humans; Liposomes; Mitoxantrone; Receptors, Estrogen | 2021 |